Paul Wotton Insider Profile
4 Followers
Paul Wotton, Director at Vericel, holds 18.80K shares in Vericel (Ticker: VCEL), holds 267.50K shares in Ocata Therapeutics (Ticker: OCAT), holds 937.73K shares in Antares Pharma (Ticker: ATRS). Most recently, Paul Wotton Sold ― shares of Vericel on May 13, 2026 for an estimated value of $327.43K.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+5.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Paul Wotton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Wotton
Paul Wotton's Trading History
Vericel
May 13, 2026
Director
Informative Sell
327.43K
$755.65K
Ocata Therapeutics
Feb 11, 2016
―
Uninformative Sell
2.36M
$2.27M
Antares Pharma
Jun 02, 2014
―
Uninformative Buy
―
$5.24M
List of latest transactions for each holding click on a transaction to see Paul Wotton's performance on stock
You May Also Like
Paul Wotton insider profile FAQ
What is the percentage of profitable transactions made by Paul Wotton?
The percentage of profitable transactions made by Paul Wotton is 50%.
What is the average return per transaction made by Paul Wotton?
The average return per transaction made by Paul Wotton is 5.40%.
What stocks does Paul Wotton hold?
Paul Wotton holds: VCEL, OCAT, ATRS stocks.
What was Paul Wotton’s latest transaction?
Paul Wotton latest transaction was an Informative Sell of $327.43K.
What was Paul Wotton's most profitable transaction?
Paul Wotton’s most profitable transaction was an Informative Sell of VCEL stock on May 17, 2021. The return on the trade was 43.70%.
What is Paul Wotton's role in Vericel?
Paul Wotton's role in Vericel is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.